“A Phase I Study of SB26 in Healthy Volunteers”
This study is a Phase I, randomized double-blind, placebo-controlled (within a dose group), single and multiple rising dose study of the intravenous administration of SB26 in healthy volunteers.
Drug - SB26
SB26 administered intravenously
Drug - Placebo
Placebo administered intravenously
A Randomized, Double-blind, Placebo-controlled, Single and Multiple Rising Dose Study to Explore the Safety, Tolerability, and Pharmacokinetics of Intravenous Doses of SB26 in Healthy Volunteers